Thomas, S.D.; Abdalla, S.; Eissa, N.; Akour, A.; Jha, N.K.; Ojha, S.; Sadek, B.
Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer’s Disease, Parkinson’s Disease, and Autism Spectrum Disorder. Pharmaceuticals 2024, 17, 831.
https://doi.org/10.3390/ph17070831
AMA Style
Thomas SD, Abdalla S, Eissa N, Akour A, Jha NK, Ojha S, Sadek B.
Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer’s Disease, Parkinson’s Disease, and Autism Spectrum Disorder. Pharmaceuticals. 2024; 17(7):831.
https://doi.org/10.3390/ph17070831
Chicago/Turabian Style
Thomas, Shilu Deepa, Sabna Abdalla, Nermin Eissa, Amal Akour, Niraj Kumar Jha, Shreesh Ojha, and Bassem Sadek.
2024. "Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer’s Disease, Parkinson’s Disease, and Autism Spectrum Disorder" Pharmaceuticals 17, no. 7: 831.
https://doi.org/10.3390/ph17070831
APA Style
Thomas, S. D., Abdalla, S., Eissa, N., Akour, A., Jha, N. K., Ojha, S., & Sadek, B.
(2024). Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer’s Disease, Parkinson’s Disease, and Autism Spectrum Disorder. Pharmaceuticals, 17(7), 831.
https://doi.org/10.3390/ph17070831
